AI
Saturday, June 27, 2020 3:03:00 PM
Anavex 2-73 USA Phase 2 Rett syndrome trial Part A after just 7 weeks of treatment at a low dose of 5 mg
We can expect efficacy in the PDD trial within 14 weeks.
Click on each of the images below:
https://www.anavex.com/wp-content/uploads/2020/02/Anavex-Presentation-February-2020.pdf
Good luck and GOD bless,
Recent AVXL News
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
